It has been reported that 31% of patients with colorectal cancer (CRC) exhibited higher SphK1 expression and it was correlated with higher histological grade, vascular invasion, lymphatic invasion, distance metastasis, and lower overall survival times [70]. The gene discussed is SPHK1; the disease is colorectal carcinoma.